In cancers, cadherins rather tend to play a role of tumor suppressor genes and their expression is often lost during carcinogenesis [43]; however, during the epithelio–mesenchymal transition, a cadherin “switch” mechanism has been reported with E-cadherin expression decreasing while N-cadherin expression is increasing [44]. This evidence concerns the gene CDH17 and cancer.